Amplia Therapeutics Limited
ASX:ATX.AX
0.068 (AUD) • At close March 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||
| Net Income
| -4.503 | -6.242 | -3.644 | -2.281 | -2.219 | -1.87 | -4.298 | -7.076 | -4.943 | -5.237 | -4.495 | -3.388 | -3.254 | -2.443 | -4.065 |
| Depreciation & Amortization
| 0.086 | 0.073 | 0.003 | 0.001 | 0.001 | 0.002 | 0.02 | 0.037 | 0.568 | 1.548 | 1.475 | 1.329 | 1.308 | 1.33 | 1.406 |
| Deferred Income Tax
| 0 | 0.314 | -0.889 | -1.345 | -0.279 | -0.648 | -1.271 | -1 | 0.919 | 0.339 | -0.618 | -0.238 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0.209 | 0.061 | 0.354 | 0.203 | 0.244 | 0.075 | 0.929 | 0.228 | 0.178 | 0.623 | 0.214 | 0 | 0 | 0 |
| Change In Working Capital
| -2.045 | 0.67 | -0.822 | -0.99 | -0.075 | 0.404 | 1.197 | 0.071 | -1.147 | -0.517 | -0.005 | 0.025 | 0.295 | -0.033 | 0.179 |
| Accounts Receivables
| 0 | 0.68 | -0.825 | -1.018 | -0.059 | 0.404 | 1.197 | 0.071 | -1.147 | -0.517 | -0.005 | 0.025 | 0.047 | -0.058 | 0.009 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | -0.011 | 0.004 | 0.029 | -0.016 | 0.247 | -0.628 | -0.122 | 0.578 | 0 | 0 | 0 | 0.258 | 0.018 | 0.111 |
| Other Working Capital
| -2.045 | 0 | -0 | 0 | 0 | -0.247 | 0.628 | 0.122 | -0.578 | 0 | 0 | 0 | -0.01 | 0.007 | 0.059 |
| Other Non Cash Items
| 1.335 | -0.313 | 0.889 | 1.345 | 0.282 | 0.881 | 0.729 | -0.123 | 0.579 | 0.049 | 1.416 | 0.304 | 0.379 | -0.458 | 0.442 |
| Operating Cash Flow
| -5.127 | -5.29 | -4.402 | -2.916 | -2.088 | -0.987 | -3.549 | -6.162 | -4.714 | -3.978 | -1.605 | -1.755 | -1.272 | -1.603 | -2.037 |
| Investing Activities: | |||||||||||||||
| Investments In Property Plant And Equipment
| -0.002 | -0.018 | -0.014 | -0.005 | 0 | -0.003 | -0.004 | -0.047 | -0.039 | -0.025 | -0.001 | 0 | -0.007 | -0.006 | -0.012 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0.006 | 0 | 0 | 0 | 0 | 0 | 0.005 | 0.006 | 0.005 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.006 | 0 |
| Other Investing Activites
| 0 | -0.041 | -0.012 | 0 | 0 | 0 | -0 | -0.001 | -0 | -0 | 0 | 0.007 | -0 | 0 | -0 |
| Investing Cash Flow
| -0.002 | -0.058 | -0.027 | -0.005 | 0 | -0.003 | 0.002 | -0.047 | -0.039 | -0.025 | -0.001 | 0.007 | -0.002 | 0.005 | -0.007 |
| Financing Activities: | |||||||||||||||
| Debt Repayment
| -0.633 | 0 | 2.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.533 | 0 | 0 | 0 | 0.286 |
| Common Stock Issued
| 0 | 0.021 | 15.089 | 3.663 | 1.958 | 0 | 0 | 8.715 | 4.008 | 0 | 10.044 | 0 | 0.235 | 2.675 | 1.384 |
| Common Stock Repurchased
| 0 | 0 | -1.182 | -0.4 | -0.191 | -0.012 | -0.013 | -0.202 | -0.066 | 0 | -1.146 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.255 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.14 | -0.105 | 15.089 | 0 | 0 | -0.012 | -0.013 | 0 | 0 | 0 | 0 | 0.715 | 0 | 0 | 0 |
| Financing Cash Flow
| -0.773 | -0.084 | 17.189 | 3.663 | 1.958 | -0.012 | -0.013 | 8.715 | 4.008 | -0.002 | 9.432 | 0.715 | 0.235 | 2.675 | 1.671 |
| Other Information: | |||||||||||||||
| Effect Of Forex Changes On Cash
| 0.031 | 0.08 | -0 | -0.001 | -0.003 | 0.014 | 0.026 | 0.056 | -0.143 | 0.152 | -0.003 | -0.012 | 0 | 0 | 0 |
| Net Change In Cash
| -5.871 | -5.352 | 12.76 | 0.74 | -0.133 | -0.988 | -3.534 | 2.563 | -0.888 | -3.852 | 7.824 | -1.045 | 0 | 0 | 0 |
| Cash At End Of Period
| 3.385 | 9.257 | 14.609 | 1.848 | 1.108 | 1.241 | 2.229 | 5.763 | 3.201 | 4.089 | 7.941 | 0.117 | 1.167 | 2.081 | 1.111 |